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Background: Iron-catalyzed oxidative stress contributes to lung injury after exposure to various 
toxins, including cigarette smoke. An oxidant/antioxidant imbalance is considered to play a 
critical role in the pathogenesis of COPD. Ferritin is a key protein in iron homeostasis, and its 
capacity to oxidize and sequester the metal preventing iron prooxidant activity implicates its 
possible role in the alteration of antioxidant imbalance. We investigated the relationship among 
cigarette smoking, lung function, and serum ferritin concentration in a large cohort representa-
tive of the Korean adult population.
Materials and methods: Among 50,405 participants of the Korean National Health and 
Nutrition Examination Survey from 2010 to 2014, 15,239 adult subjects older than 40 years 
with serum ferritin levels and spirometric data were selected for this study.
Results: The mean age was 56.5 years for men (43%) and 56.9 years for women (57%). The 
prevalence of airway obstruction was 13.4%, which was significantly higher in men than in 
women, and increased in former or current smokers. The median levels of serum ferritin were 
highest in the airway obstruction group, followed by the restrictive pattern group, and lowest in 
the normal lung function group. The median ferritin levels were increased by smoking status and 
amounts in each spirometric subgroup. In multivariable regression analysis, serum ferritin was 
positively associated with forced expiratory volume in 1 second and forced expiratory volume 
in 1 second/forced vital capacity, whereas the smoking amount was negatively associated with 
the adjustment with age, sex, height, and weight.
Conclusion: Serum ferritin levels were increased in former or current smokers and were 
increased with smoking amount in all subgroups of participants categorized according to 
spirometric results. The result was also evident in the subgroups divided by obstructive severity. 
While smoking amount was inversely related to lung function, higher levels of serum ferritin 
were associated with enhanced spirometric results in a representative sample of the general 
Korean adult population. Future prospective studies will be needed to clarify the causality 
between serum ferritin and lung functions and their role in COPD morbidity.
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Introduction
Although iron is an essential nutrient widely used for normal cell function, elevated 
iron concentrations in the lungs are associated with an increased risk of pulmonary 
injury. Iron-catalyzed oxidative stress contributes to lung injury after exposure to 
various toxins, including cigarette smoke. Smoking has been suggested to increase 
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the concentration of iron in the alveolar macrophages and 
bronchoalveolar lavage fluid to very high levels and to alter 
iron homeostasis, both in the lung and systemically.1–4
COPD is one of the most common lung diseases, affect-
ing ~10% of the population older than 40 years worldwide,5 
while a recent Korean nationwide surveillance indicated its 
higher prevalence in the Korean population.6 An imbalance 
between oxidants and antioxidants is considered to play a 
critical role in COPD pathogenesis,7,8 while cigarette smoking 
is a key risk factor for COPD development, and most COPD 
patients are current or former smokers.9
Ferritin, a ubiquitous intracellular protein, is one of the 
key proteins that regulates body iron homeostasis and is a 
marker of the iron store.10 This study investigated the rela-
tionship among cigarette smoking, lung function, and serum 
ferritin concentration, using data collected from subjects 
participating in the Korean National Health and Nutrition 
Examination Survey (KNHANES) from 2010 to 2014.
Materials and methods
study population
The KNHANES is a cross-sectional survey of health-related 
behaviors, health conditions, and the nutritional state of the 
Korean population (adults and children) and yields basic 
statistics for establishing health policies. For this study, 
data from the 2010–2014 surveys (KNHANES IV–V) were 
used, which employed a stratified, multiple-stage, clustered-
probability design to select a representative sample of nonin-
stitutionalized civilians from among the Korean population. 
These data comprised information on age, ethnicity, sex, 
height, weight, smoking status, residency, household income, 
past history of pulmonary tuberculosis and asthma, and 
prebronchodilator spirometry values.
The study protocol was approved by the institutional 
review board of Yonsei University Health Service, Severance 
Hospital (approval number: 4-2006-0101), and was conducted 
in accordance with the Declaration of Helsinki. All the par-
ticipants in the survey provided written informed consent.
Among the KNHANES IV–V participants (N=50,405), 
all individuals older than 40 years who were examined for 
serum ferritin levels and spirometric data were included in 
this study.
spirometric tests
After explaining the procedure of spirometry to participants 
in detail, spirometry measurements were conducted by 
four technicians, each of whom underwent two education 
sessions on pulmonary function testing and quality control, 
and the principal investigator determined whether they met 
the criteria for acceptability and reproducibility. Spirometry 
(Vmax 2130 Dry Rolling-seal Spirometer; SensorMedics, 
Yorba Linda, CA, USA) was performed according to the 
guidelines of the American Thoracic Society/European 
Respiratory Society for standardizing the pulmonary function 
tests.11 Data that produced two acceptable spirometry curves, 
ie, showing the start of the test and expiration for 6 seconds, 
with the greatest difference between the two measurements of 
forced expiratory volume in 1 second (FEV
1
) and forced vital 
capacity (FVC) 150 mL, were included in the analysis.
“Airway obstruction” was defined using the ratio of 
FEV
1
 to FVC (FEV
1
/FVC) 70% as a fixed cut-off point 
according to the guidelines set by the Global Initiative for 
Chronic Obstructive Lung Disease (GOLD).12 The severity of 
airway obstruction was classified as “mild” (FEV
1
 80% pre-
dicted, GOLD stage I), “moderate” (50% FEV
1
 80% 
predicted, GOLD stage II), and “severe” (FEV
1
 50% 
predicted, GOLD stages III–IV). In addition, “normal lung 
function” was defined as FEV
1
/FVC 70% and FVC 80% 
predicted. A “restrictive spirometric pattern” was defined as 
FEV
1
/FVC 70% and FVC 80% predicted.
serum ferritin level measurement
Serum ferritin was measured by immunoradiometric assay 
using a 1470 Wizard Gamma Counter (PerkinElmer Inc., 
Waltham, MA, USA).
statistical analyses
Data were analyzed using SAS v9.2 (SAS Institute Inc., Cary, 
NC, USA). Baseline characteristics were summarized using 
frequencies and percentages to describe categorical variables 
and compared using the chi-square test. Serum ferritin levels 
were compared using analysis of variance and are presented as 
the median and interquartile range (IQR). Serum ferritin level 
was logarithmically transformed because of the skewed nature 
of its distribution. Multivariable linear regression analysis 
using a stepwise backward technique was performed to assess 
the correlation among lung function, cigarette smoking, and 
serum ferritin concentration in a multivariable model adjusted 
for age, sex, height, and weight. Statistical significance for 
all analyses was accepted at a level of P0.05.
Results
Population characteristics according 
to spirometric patterns
The baseline characteristics of the 15,239 study subjects are 
summarized in Table 1. The mean age was 56.5 years for 
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men and 56.9 years for women. The study population was 
grouped into three subgroups according to the spirometric 
results: normal pattern (n=11,477), restrictive pattern 
(n=1,727), and obstructive pattern (airway obstruction; 
n=2,035). Of all 15,239 study individuals, the prevalence 
of airway obstruction was 13.4%, which was significantly 
higher in men (22.3%) than in women (6.5%), while a normal 
spirometric pattern was more common in women (82.9%) 
than in men (65.4%). The prevalence of airway obstruction 
was increased in ever smokers (former or current) and with 
the amount smoked. Both restrictive and obstructive patterns 
were more common among the older age groups. Anemia 
was more frequent in the restrictive subgroup (10.1%) than 
in those with normal lung function (8.6%) or with airway 
obstruction (7.6%). In the obstructive subgroup (n=2,035), 
the presence of anemia did not differ significantly accord-
ing to the severity of obstruction (Table 1). Additionally, 
the prevalence of airway obstruction was higher in subjects 
living in urban areas (16.8%) than in those living in a rural 
area (12.2%; P0.001) and was more frequently observed 
with a higher household income (first quartile: 21.9%, sec-
ond quartile: 14%, third quartile: 10.6%, and fourth quartile: 
8.8%; P0.001). The prevalence of airway obstruction was 
28.8% in individuals with a history of pulmonary tubercu-
losis (n=1,040) and 12.2% in those without such a history 
(n=14,199; P0.001). Furthermore, airway obstruction 
was more prevalent in subjects with asthma (n=740) than 
in those without this condition (n=14,499; 36.5% vs 12.2%; 
P0.001).
serum ferritin level of the study 
populations
Table 2 shows the median levels of serum ferritin in the three 
groups with normal lung function, a restrictive spirometric 
pattern, and airway obstruction, according to age groups, 
sex, smoking status, and smoking amount. The airway 
obstruction group had a higher serum ferritin level in all age 
groups. The median levels of serum ferritin were highest in 
the airway obstruction group (83.9 µg/L) (IQR: 50.3–138.9), 
followed by the restrictive pattern group (74.6 µg/L) (IQR: 
42.6–128.3), and lowest in the normal lung function group 
(62.3 µg/L) (IQR: 33.9–104.8). Ex- or current smokers had 
higher serum ferritin levels than never smokers in all three 
groups categorized by spirometric pattern.
Although women had lower levels of serum ferritin than 
men in all three spirometric groups, the level of serum ferritin 
was significantly lower in women with a normal spirometric 
pattern than in women with an obstructive pattern (45.3 µg/L 
vs 55.9 µg/L). Conversely, among the women with airway 
obstruction (n=562), the serum ferritin showed a trend toward 
a lower level in those with severe obstruction (38.3 µg/L 
vs 56.6 µg/L) than those with mild obstruction (P=0.404). 
For men, the level of serum ferritin was higher in those 
with a normal spirometric pattern than in those with airway 
Table 1 Characteristics of study population according to spirometric results
Characteristics Total Spirometric results Obstructive severity
Normal Restrictive Obstructive P-value Mild Moderate Severe P-value
number (%) 15,239 11,477 (75.3) 1,727 (11.3) 2,035 (13.4) 907 (6.0) 1,023 (6.7) 105 (0.7)
age group (years)
40–49 4,610 4,106 (89.1) 339 (7.4) 165 (3.6) 0.001 55 (33.3) 108 (65.5) 2 (1.2) 0.323
50–59 4,626 3,736 (80.8) 464 (10.0) 426 (9.2) 175 (41.1) 225 (52.8) 26 (6.1)
60–69 3,728 2,458 (65.9) 540 (14.5) 730 (19.6) 307 (42.1) 390 (53.4) 33 (4.5)
70 2,275 1,177 (51.7) 384 (16.9) 714 (31.4) 370 (51.8) 300 (42.0) 44 (6.2)
sex
Men 6,613 4,325 (65.4) 815 (12.3) 1,473 (22.3) 0.001 664 (45.1) 728 (49.4) 81 (5.5) 0.001
Women 8,626 7,152 (82.9) 912 (10.6) 562 (6.5) 243 (43.2) 295 (52.5) 24 (4.3)
smoking status
never smoker 9,223 7,569 (82.1) 1,015 (11.0) 639 (6.9) 0.001 268 (41.9) 347 (54.3) 24 (3.8) 0.029
exsmoker 3,180 2,026 (63.7) 395 (12.4) 759 (23.9) 358 (47.2) 353 (46.5) 48 (6.3)
Current smoker 2,836 1,882 (66.4) 317 (11.2) 637 (22.5) 281 (44.1) 323 (50.7) 33 (5.2)
smoking amount (pack-year)
0 9,225 7,571 (82.1) 1,015 (11.0) 639 (6.9) 0.001 268 (41.9) 347 (54.3) 24 (3.8) 0.002
0–19.9 2,702 1,951 (72.2) 297 (11.0) 454 (16.8) 234 (51.5) 195 (43.0) 25 (5.5)
20 3,312 1,955 (59.0) 415 (12.5) 942 (28.4) 405 (43.0) 481 (51.1) 56 (5.9)
anemia
Yes 740 990 (8.6) 175 (10.1) 155 (7.6) 0.023 73 (8.1) 73 (7.1) 9 (8.6) 0.700
no 14,499 10,487 (91.4) 1,552 (89.9) 1,880 (92.4) 834 (92.9) 950 (92.9) 96 (91.4)
Notes: Data are presented as numbers (percentages) for categorical variables. Anemia was defined as 13 g/dl hemoglobin for men and 12 g/dl hemoglobin for women. 
P-value was calculated using one-way analysis of variance.
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obstruction (102.8 µg/L vs 98.8 µg/L; P=0.198). Addition-
ally, the serum ferritin level was higher in men than in women 
in all subgroups determined by smoking status. Because of 
the skewed nature of the distribution, serum ferritin levels 
were also logarithmically transformed, and the median levels 
of the log-transformed serum ferritin (SD) were 1.91 (0.37), 
1.84 (0.41), and 1.74 (0.43) in obstructive, restrictive, and 
normal spirometric patterns, respectively (P0.001). In the 
male population, the median level of the log-transformed 
serum ferritin was highest in current smokers, while it was 
highest in exsmokers in women (Table 2).
Predictors of decreased lung function
We performed multivariable linear regression analyses to 
determine the relationships among spirometric results (FEV
1
 
and FEV
1
/FVC), serum ferritin, and smoking amounts. After 
adjustment for age, sex, height, and weight, serum ferritin 
levels were positively associated with FEV
1
 and FEV
1
/FVC, 
whereas the smoking amount was negatively associated with 
these values in our study population (Table 3).
Discussion
In this cross-sectional study, we analyzed the associations 
among serum ferritin levels, cigarette smoking, and lung 
function in a large cohort derived from the Korean population 
older than 40 years. Increased amounts of cigarette smoking 
were related to higher serum ferritin levels, while lower 
serum ferritin levels were significantly related to decrease in 
FEV
1
 and FEV
1
/FVC values. The positive correlation among 
log-transformed ferritin levels, smoking amounts, and lung 
function assessed by spirometric data remained significant 
after adjustment for independent covariates, such as age, 
sex, height, and weight. Collectively, these findings suggest 
that the iron store may affect pulmonary physiology and, 
possibly, the risk of airway obstruction, while smoking may 
alter iron homeostasis.
Iron is an essential micronutrient that is used in almost 
every aspect of normal cell function. However, its ability to 
catalyze the formation of reactive oxygen species can also be 
a health threat, which can lead to oxidative stress and damage 
cellular membranes.13 Cigarette smoke contains numerous oxi-
dants and prooxidants capable of producing free radicals and 
enhancing oxidative stress.14 Previous studies have suggested 
the influence of cigarette smoking on iron status by demon-
strating cigarette smoke-induced release of iron from ferritin 
by aqueous extracts of cigarette smoke15 and that such iron 
mobilization acts as a specific prooxidant mechanism during 
smoking.16 In addition to other studies showing the increased T
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lavage iron stores in smokers,2,17 Ghio et al4 in their animal 
experiments suggested an alteration in iron homeostasis from 
cigarette smoke exposure. More specifically, they have shown 
that such exposure leads to iron accumulation that is dependent 
on particulates in the smoke and that this change affects oxida-
tive stress, which is responsible for tissue inflammation after 
smoking. They suggested that the complexation of host iron 
by particulate matter in the tar phase of cigarette smoke will 
alter iron homeostasis, both in the lung and systemically.4
In order to regulate iron-catalyzed oxidative stress, 
lung epithelial cells can rapidly increase the expression 
of ferritin protein.1 Ferritin restricts the capacity of iron to 
generate reactive oxygen species and free radicals via iron 
sequestration and, thus, serves as an antioxidant protein.18 
Using human lavage samples, Ghio et al4 demonstrated 
significantly increased ferritin concentrations in healthy 
smokers and smokers with COPD when compared with 
healthy nonsmokers. Using National Health and Examination 
Survey III data from 7,000 subjects, they also demonstrated 
significant increases in serum iron and ferritin levels and 
transferrin saturation among smokers relative to nonsmokers. 
A prior study by Touitou et al19 reported significantly higher 
levels of plasma ferritin in smokers than in nonsmokers in 
an elderly population. Our study extends these observations 
in a larger cohort of 15,000 subjects, representative of the 
general Korean population.
In our results, the levels of serum ferritin were highest 
among subjects with an obstructive pattern, grouped accord-
ing to spirometric data, and defined as FEV
1
/FVC 70%. 
This indicates the impact of smoking on serum ferritin levels, 
considering that ~70% of those with an obstructive pattern 
were former or current smokers. Alternatively, in the subgroup 
analysis of only subjects with an obstructive pattern, the levels 
of serum ferritin were decreased in the subgroups with severe 
obstruction as defined by sex and smoking. Although the role 
of iron in COPD has not been clarified, our results of a positive 
correlation between serum ferritin levels and lung function 
parallel the findings of studies that explored iron status in 
other respiratory diseases. Sharkey et al20 have demonstrated 
that the initial serum ferritin levels measured among patients 
with acute respiratory distress syndrome predicts the develop-
ment of this syndrome and multiple organ failure. Increased 
concentrations of iron in the lavage fluid of patients with 
cystic fibrosis have also been observed.21 Alternatively, iron 
deficiency has been shown to be associated with reduced lung 
function in a large cohort of North American women.22 In the 
context of patients with COPD, a cross-sectional study has 
reported associations between iron deficiency and reduced 
exercise tolerance and more frequent exacerbations.23 Fur-
ther studies are needed to clarify the role of iron status in the 
development of airway obstructive diseases.
Although a major strength of this study is the large number 
of representative participants and their stratification by lung 
function, there are several limitations to be accounted for. 
First, serum ferritin is an acute-phase reactant and may be 
increased in the presence of inflammation. Given the lack of 
data on inflammation, infection, or liver disease in our study 
population, we cannot rule out the potential confounding 
effect related to the ferritin levels. Similarly, we measured 
only serum ferritin levels as a marker of iron status, and other 
iron profiles, such as serum iron levels, transferrin, and total 
iron-binding capacity, could not be included in the analyses. 
Finally, due to the nature of cross-sectional cohort studies, 
causation could not be investigated and a reverse causality 
cannot be excluded in this study. Therefore, we could not 
determine whether the positive association between FEV
1
 
and FEV
1
/FVC and serum ferritin levels observed in this 
study indicated enhanced detoxification of iron in individu-
als with better lung functions, or if adequate body iron stor-
age per se favorably affected spirometric results.
Conclusion
Serum ferritin levels were increased in former or current 
smokers and were increased with smoking amount in all 
Table 3 Multivariable linear regression analysis for relationship between serum ferritin levels and FeV1 and FeV1/FVC
Variables FEV1 (%) predicted FEV1/FVC (%) predicted
β SE P-value R2 (adjusted) β SE P-value R2 (adjusted)
serum ferritin (log-transformed) 0.02269 0.00840 0.007 0.6819 0.00294 0.00141 0.037 0.2801
age (years) −0.02539 0.00032 0.001 −0.00289 0.00005 0.001
sex (men) −0.41599 0.01116 0.001 0.01668 0.00187 0.001
smoking amount (pack-year) −0.00415 0.00023 0.001 −0.00084 0.00004 0.001
height (cm) 0.03225 0.00065 0.001 −0.00184 0.00011 0.001
Weight (kg) 0.00130 0.00041 0.001 0.00104 0.00007 0.001
Note: serum ferritin level was logarithmically transformed because of the skewed nature of its distribution.
Abbreviations: FeV1, forced expiratory volume in 1 second; FVC, forced vital capacity; se, standard error.
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subgroups of participants categorized according to spiro-
metric results. The result was also evident in the subgroups 
divided by obstructive severity. While the smoking amount 
was inversely related to lung function, a higher level of 
serum ferritin was associated with enhanced spirometric 
results in a representative sample of the general Korean 
adult population. Given the findings in this study and the 
increasing incidence of COPD worldwide, future prospec-
tive studies will be needed to clarify the causality between 
serum ferritin levels and lung function and its role in COPD 
morbidity.
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